Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by TheEdioton Mar 19, 2020 11:59pm
83 Views
Post# 30829190

RE:Chloroquine

RE:Chloroquine

LOL - Fauci was standing around the corner when Trump DID describe as such.  But, Trump's job is to make it all look hopeful while preparing for the worst.  They contradict each other constantly... double-speak that says they have nothing even remotely definitive to report and won't for quite awhile.

There's a story about the Jewish community here in Canada using it here as well, but it can be toxic, has all kinds of side-effects, and France is testing a milder variation. But there are side-effects and conditional health histories still in play.  This isn't just a pop-and-good-to-go for the world by any means.

They still aren't as close to a treatment for the critical lung aspect as ready-to-go AmnioBoost is.  Even the report from Bellus Health today that jumped them 20% isn't in the same category or targets the same mechanics.  I urge folks to ready the full HTML/PDF report link (check the charts, release dates, patient profiles, etc.), not just the abstract.  Here's the link to the full HTML version..

https://www.aginganddisease.org/article/2020/2152-5250/ad-11-2-216.shtml

We're unique here - if the trials produce the same results as the existing test refered to hear (which were unequivocally impress - intensive care to recovery in a handful of day!?!?), this company, drug, and stock should become extremely high profile overnight.

When the trial news surfaces, you don't want to be sitting on the sidelines...

Once again, GLTA, especially the patients who could have their lives saved if AmnioBoost is as effective as we all hope and believe it will be.

<< Previous
Bullboard Posts
Next >>